Hemostasis Closes Acquisition of Fiagon Medical Technologies
“We are pleased to have successfully closed this strategic acquisition and welcome the Fiagon team," said Keith Roberts, President and CEO of Hemostasis. "Fiagon represents a strategic technology acquisition for Hemostasis that immediately expands our portfolio of ENT technology offerings and complements our industry leading PosiSep sinus dressings, NexStat hemostats and Vectra drug delivery microsponges. Fiagon develops, and commercializes globally, innovative electromagnetic surgical navigation systems and navigable sinuplasty balloons. The combination of the Hemostasis and Fiagon portfolios will provide optimized treatment and healing technologies for sinus surgeons and patients.”
Founded in 2007, Fiagon’s mission is to improve patient outcomes by equipping physicians with its proprietary, easy-to-use, accurate and integrated surgical navigation solutions. Fiagon’s Cube 4D navigation system features groundbreaking VirtuEye® one-click photoregistration. It supports both routine and complex ENT procedures enabling surgeons to track the full range of instruments deployed during a functional endoscopic sinus surgery (FESS) procedure. Fiagon’s proprietary instruments are tip-tracked and do not require calibration making them extremely intuitive and easy to use. The instruments and Vensure® sinuplasty balloon can be bent and adjusted to accommodate various anatomical structures within the sinuses, allowing ENT surgeons to maximize efficiency within their procedures.
“We are excited to join the team at Hemostasis, an innovation and technological leader with an advanced, technological platform in the large and attractive global ENT market,” said Dr. Kai Desinger, President and CEO of Fiagon Group. “The combination of Hemostasis’ compelling product offerings coupled with its deep commercial leadership expertise and impressive sales force offers a unique opportunity for us to jointly leverage our core innovation and commercialization competencies. We look forward to working with the Hemostasis team to expand market penetration of our navigation and balloon technologies globally.”
About Hemostasis LLC
Hemostasis is a company transforming care for patients with ear, nose and throat conditions. It is the innovation and technology leader in sinus dressings and wound healing technologies for sinus surgery. The Company’s sinus dressings, hemostats and drug delivery microsponges are designed to provide mechanical spacing, hemostasis and enhanced wound healing to the surgical site. In addition, Hemostasis is continuing to expand its portfolio of products based on the Company’s unique technologies and is committed to broadening patient access to less invasive and more cost-effective care.
About Fiagon Medical Technologies
Fiagon develops and manufactures state-of-the-art surgical navigation equipment with its proprietary tip-tracked technology. Over the past ten years Fiagon, along with world-renowned physicians, changed the standard of ENT navigation with its easy-to-use electromagnetic based technology. This unique technology is also currently used in oral and maxillofacial surgery, neurosurgery and spine surgery, outside the US, mainly in Europe and Asia.
